Sung Yun Cho - Concepedia

Author

Sung Yun Cho

Korea Research Institute of Chemical Technology ORCID

Also Known As

Byoung Chul Park, SUNG YUN CHO, Sung Yun Cho

Publications

810

Citations

H-Index

Concepts

All Affiliations

Korea Research Institute of Chemical Technology Korea University of Science and Technology Chungnam National University Gyeongsang National University Chungbuk National University

About

Sung Yun Cho is an author at Korea Research Institute of Chemical Technology specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	456
2	Natural Sciences	9	9	336
3	Biochemistry	7	7	302
4	Engineering	3	3	40
5	Biomolecular Engineering	1	1	14

Sung Yun Cho

Publications

676

Citations

H-Index

Page 1

	Year	Citations
Synthesis and biological evaluation of rhodanine derivatives as PRL-3 inhibitors Jin Hee Ahn, Seung Jun Kim, Woul Seong Park, Bioorganic & Medicinal Chemistry Letters Rhodanine DerivativesBioorganic ChemistryBiochemistryMedicineNatural Sciences	2006	149
Synthesis and PTP1B inhibition of 1,2-naphthoquinone derivatives as potent anti-diabetic agents Jin Hee Ahn, Sung Yun Cho, Jae Du Ha, Bioorganic & Medicinal Chemistry Letters Ptp1b InhibitionMedicinal ChemistryBiochemistryPotent Anti-diabetic AgentsMedicine	2002	63
Novel c-Met inhibitor suppresses the growth of c-Met-addicted gastric cancer cells Chi Hoon Park, Sung Yun Cho, Jae Du Ha, BMC Cancer	2016	41
Design and synthesis of 3-(4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridin-2-yl)-1H-quinolin-2-ones as VEGFR-2 kinase inhibitors Sun‐Young Han, Jie Won Choi, Jeon Yang, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryMedicinePharmacologyVegfr-2 Kinase InhibitorsPharmaceutical Chemistry	2012	40
Discovery of a potent small molecule SIRT1/2 inhibitor with anticancer effects Gildon Choi, Jong‐Kook Lee, Jeong Yeon Ji, International Journal of Oncology	2013	36
PTP-1B inhibitors: Cyclopenta[d][1,2]-oxazine derivatives Sung Yun Cho, Ji Yoen Baek, Sang Sub Han, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryPharmaceutical ChemistryBiochemistryMedicineNatural Sciences	2005	30
Novel bis-ortho-alkoxy-para-piperazinesubstituted-2,4-dianilinopyrimidines (KRCA-0008) as potent and selective ALK inhibitors for anticancer treatment Chi Hoon Park, Hyeonjeong Choe, In-Young Jang, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistrySelective Alk InhibitorsPharmaceutical ChemistryMedicinePharmacology	2013	23
Design and synthesis of novel 3-(benzo[d]oxazol-2-yl)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine derivatives as selective G-protein-coupled receptor kinase-2 and -5 inhibitors Sung Yun Cho, Byung Ho Lee, Heejung Jung, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryPyridin-2-amine DerivativesMedicineNatural Sciences	2013	20
Design and synthesis of triazolopyridazines substituted with methylisoquinolinone as selective c-Met kinase inhibitors Jae Wook Ryu, Sun‐Young Han, Jeong In Yun, Bioorganic & Medicinal Chemistry Letters Combinatorial ChemistryMedicinal ChemistryHeterocyclicNatural SciencesMedicine	2011	19
Circulating Small Extracellular Vesicles Activate TYRO3 to Drive Cancer Metastasis and Chemoresistance Miso Park, Ji Won Kim, Kyu Min Kim, Cancer Research	2021	19

Page 1